{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:07:47Z","timestamp":1787501267801,"version":"build-2736575974"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.2215\/cjn.01170209","type":"journal-article","created":{"date-parts":[[2010,2,25]],"date-time":"2010-02-25T22:00:48Z","timestamp":1267135248000},"page":"874-881","source":"Crossref","is-referenced-by-count":11,"title":["Antibodies to Platelet Factor 4\u2013Heparin Complex and Outcome in Hemodialysis Patients with Diabetes"],"prefix":"10.2215","volume":"5","author":[{"given":"Vera","family":"Krane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Lilienthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Schambeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Wanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-21-20230601","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1542-4758.2007.00146.x","article-title":"Modification of cardiovascular risk in hemodialysis patients: An evidence-based review","volume":"11","author":"Johnson","year":"2007","journal-title":"Hemodial Int"},{"key":"R3-21-20230601","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000089435","article-title":"Dialysis patients and cardiovascular problems: Can technology help solve the complex equation?","volume":"24","author":"Ronco","year":"2006","journal-title":"Blood Purif"},{"key":"R4-21-20230601","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-2004-823004","article-title":"Newer insights on the mechanism of heparin-induced thrombocytopenia","volume":"30","author":"Walenga","year":"2004","journal-title":"Semin Thromb Hemost"},{"key":"R6-21-20230601","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.ahj.2007.03.013","article-title":"Beyond the platelet count: Heparin antibodies as independent risk predictors","volume":"153","author":"Stribling","year":"2007","journal-title":"Am Heart J"},{"key":"R7-21-20230601","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.ki.5002631","article-title":"Increased mortality in hemodialysis patients having specific antibodies to the platelet factor 4-heparin complex","volume":"73","author":"Carrier","year":"2008","journal-title":"Kidney Int"},{"key":"R8-21-20230601","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.surg.2004.07.004","article-title":"Heparin-associated antiplatelet antibodies increase morbidity and mortality in hemodialysis patients","volume":"136","author":"Mureebe","year":"2004","journal-title":"Surgery"},{"key":"R9-21-20230601","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1111\/j.1542-4758.2005.01163.x","article-title":"Role of platelet factor 4-heparin complex antibody (HIT antibody) in the pathogenesis of thrombotic episodes in patients on hemodialysis","volume":"9","author":"Nakamoto","year":"2005","journal-title":"Hemodial Int"},{"key":"R10-21-20230601","doi-asserted-by":"crossref","first-page":"995","DOI":"10.4065\/80.8.995","article-title":"Association of heparin-dependent antibodies and adverse outcomes in hemodialysis patients: A population-based study","volume":"80","author":"Pena de la Vega","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"R11-21-20230601","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000080241","article-title":"Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): Demographic and baseline characteristics","volume":"27","author":"Wanner","year":"2004","journal-title":"Kidney Blood Press Res"},{"key":"R12-21-20230601","doi-asserted-by":"crossref","first-page":"S222","DOI":"10.1046\/j.1523-1755.1999.07158.x","article-title":"Rationale and design of a trial improving outcome of type 2 diabetics on hemodialysis. Die Deutsche Diabetes Dialyse Studie Investigators","volume":"71","author":"Wanner","year":"1999","journal-title":"Kidney Int Suppl"},{"key":"R13-21-20230601","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N Engl J Med"},{"key":"R14-21-20230601","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1681\/ASN.V75667","article-title":"Arteriolar wall thickening, capillary rarefaction and interstitial fibrosis in the heart of rats with renal failure: The effects of ramipril, nifedipine and moxonidine","volume":"7","author":"Tornig","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"R15-21-20230601","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1681\/ASN.V961018","article-title":"Myocyte\/capillary mismatch in the heart of uremic patients","volume":"9","author":"Amann","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"R16-21-20230601","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2215\/CJN.04571007","article-title":"The challenge of sudden death in dialysis patients","volume":"3","author":"Ritz","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R17-21-20230601","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1097\/01.ASN.0000130154.42061.C6","article-title":"Increased infarct size in uremic rats: reduced ischemia tolerance?","volume":"15","author":"Dikow","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R18-21-20230601","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/intimm\/14.2.121","article-title":"Anti-platelet factor 4\/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of microvascular endothelial cells","volume":"14","author":"Blank","year":"2002","journal-title":"Int Immunol"},{"key":"R19-21-20230601","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1111\/j.1540-8167.2006.00626.x","article-title":"The mechanisms of atrial fibrillation","volume":"17","author":"Chen","year":"2006","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R20-21-20230601","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2567.2006.02336.x","article-title":"Fibrosis in heart disease: Understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia","volume":"118","author":"Khan","year":"2006","journal-title":"Immunology"},{"key":"R21-21-20230601","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1161\/01.CIR.0000066696.57519.AF","article-title":"Anti-platelet factor 4\/heparin antibodies: An independent predictor of 30-day myocardial infarction after acute coronary ischemic syndromes","volume":"107","author":"Williams","year":"2003","journal-title":"Circulation"},{"key":"R22-21-20230601","first-page":"39","article-title":"Heparin-induced thrombocytopenia in patients treated with unfractionated heparin: Prevalence of thrombosis in a 1 year follow-up","volume":"1","author":"Mattioli","year":"2000","journal-title":"Ital Heart J"},{"key":"R23-21-20230601","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.amjcard.2004.11.026","article-title":"Incidence of antiplatelet factor 4\/heparin antibody induction in patients undergoing percutaneous coronary revascularization","volume":"95","author":"Gluckman","year":"2005","journal-title":"Am J Cardiol"},{"key":"R24-21-20230601","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1160\/TH08-03-0144","article-title":"Heparin-induced antibodies and cardiovascular risk in patients on dialysis","volume":"100","author":"Asmis","year":"2008","journal-title":"Thromb Haemost"},{"key":"R25-21-20230601","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/jcla.20076","article-title":"Prevalence of heparin-induced antibodies in patients with chronic renal failure undergoing hemodialysis","volume":"19","author":"Palomo","year":"2005","journal-title":"J Clin Lab Anal"},{"key":"R26-21-20230601","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/1076029609332802","article-title":"Increased prevalence of antiheparin platelet factor 4 antibodies in patients may be due to contaminated heparin","volume":"15","author":"Adiguzel","year":"2009","journal-title":"Clin Appl Thromb Hemost"},{"key":"R27-21-20230601","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1182\/blood-2008-04-153288","article-title":"Immune complexes formed following the binding of anti-platelet factor 4 (CXCL4) antibodies to CXCL4 stimulate human neutrophil activation and cell adhesion","volume":"112","author":"Xiao","year":"2008","journal-title":"Blood"},{"key":"R28-21-20230601","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1055\/s-0037-1615969","article-title":"A new approach in the study of the molecular and cellular events implicated in heparin-induced thrombocytopenia: Formation of leukocyte-platelet aggregates","volume":"85","author":"Khairy","year":"2001","journal-title":"Thromb Haemost"},{"key":"R29-21-20230601","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11239-005-0342-9","article-title":"Antibodies to platelet factor 4\/heparin are associated with elevated endothelial cell activation markers in patients with acute coronary ischemic syndromes","volume":"18","author":"Mascelli","year":"2004","journal-title":"J Thromb Thrombolysis"},{"key":"R30-21-20230601","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1523-1755.1999.00273.x","article-title":"Inflammation enhances cardiovascular risk and mortality in hemodialysis patients","volume":"55","author":"Zimmermann","year":"1999","journal-title":"Kidney Int"},{"key":"R31-21-20230601","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ki.2008.484","article-title":"Effect of atorvastatin on inflammation and outcome in patients with type 2 diabetes mellitus on hemodialysis","volume":"74","author":"Krane","year":"2008","journal-title":"Kidney Int"},{"key":"R32-21-20230601","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/01.CIR.99.2.237","article-title":"C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992","volume":"99","author":"Koenig","year":"1999","journal-title":"Circulation"},{"key":"R33-21-20230601","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.thromres.2006.09.014","article-title":"The prevalence of antibodies to the platelet factor 4-heparin complex and association with access thrombosis in patients on chronic hemodialysis","volume":"120","author":"Carrier","year":"2007","journal-title":"Thromb Res"},{"key":"R34-21-20230601","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1081\/JDI-100100879","article-title":"Cardiac arrhythmias and silent myocardial ischemia during hemodialysis","volume":"22","author":"Narula","year":"2000","journal-title":"Ren Fail"},{"key":"R35-21-20230601","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1046\/j.0007-1048.2002.03363.x","article-title":"The new ID-heparin\/PF4 antibody test for rapid detection of heparin-induced antibodies in comparison with functional and antigenic assays","volume":"116","author":"Eichler","year":"2002","journal-title":"Br J Haematol"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201005000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:39:29Z","timestamp":1786369169000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201005000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.01170209","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}